Literature DB >> 6182697

The differential diagnosis of pleural effusions.

S A Sahn.   

Abstract

The presence of pleural effusion enables a physician to obtain a specimen of a body cavity fluid easily. With a systematic analysis of the pleural fluid, in conjunction with the clinical features and ancillary laboratory data, a clinician should be able to arrive at either a presumptive or definitive diagnosis in approximately 90 percent of cases. Selectivity should be exercised in ordering analyses on pleural fluid. The first important deductive step is to decide whether the effusion is a transudate (due to imbalances in hydrostatic or oncotic pressures) or an exudate (inflammatory); serum protein and lactate dehydrogenase measurements will be decisive. The differential diagnosis of a transudate is relatively limited and usually easily discernible from the clinical presentation. The differential diagnosis of exudate poses a more difficult challenge for clinicians. The use of certain pleural fluid tests such as leukocyte count and differential, glucose, pH and, when indicated, pleural fluid amylase determinations, helps to narrow the differential diagnosis of an exudative pleural effusion.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6182697      PMCID: PMC1274018     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  55 in total

1.  RELATIONSHIP BETWEEN CELL TYPE, GLUCOSE CONCENTRATION, AND RESPONSE TO TREATMENT IN NEOPLASTIC EFFUSIONS.

Authors:  B CLARKSON
Journal:  Cancer       Date:  1964-07       Impact factor: 6.860

2.  TOTAL PROTEINS IN SEROUS FLUIDS IN CARDIAC FAILURE.

Authors:  V K PILLAY
Journal:  S Afr Med J       Date:  1965-02-13

3.  Pleural fluid glucose with special reference to its concentration in rheumatoid pleurisy with effusion.

Authors:  D T CARR; M H POWER
Journal:  Dis Chest       Date:  1960-03

4.  Carcinomatous involvement of the pleura: an analysis of 96 patients.

Authors:  B Chernow; S A Sahn
Journal:  Am J Med       Date:  1977-11       Impact factor: 4.965

5.  Pleural fluid pH in parapneumonic effusions.

Authors:  D E Potts; D C Levin; S A Sahn
Journal:  Chest       Date:  1976-09       Impact factor: 9.410

6.  Antibiotic concentrations in human parapneumonic effusions.

Authors:  D A Taryle; J T Good; E J Morgan; L B Reller; S A Sahn
Journal:  J Antimicrob Chemother       Date:  1981-02       Impact factor: 5.790

7.  Metastatic carcinoma of the pleura.

Authors:  P C Meyer
Journal:  Thorax       Date:  1966-09       Impact factor: 9.139

8.  [Pleural biopsies: complications and current value of Abram's needle biopsy. Apropos of 1,000 samples. Value of pleuroscopic biopsy].

Authors:  C Boutin; A Arnaud; P Farisse; J Viallat; R Choux; A Aimard; M Belnet
Journal:  Poumon Coeur       Date:  1975

9.  The diagnostic value of pleural fluid pH.

Authors:  J T Good; D A Taryle; R M Maulitz; R L Kaplan; S A Sahn
Journal:  Chest       Date:  1980-07       Impact factor: 9.410

10.  Hypoxemia after thoracentesis. A predictable and treatable condition.

Authors:  R D Brandstetter; R P Cohen
Journal:  JAMA       Date:  1979-09-07       Impact factor: 56.272

View more
  10 in total

1.  Differential diagnosis of pleural effusions.

Authors:  J B Mark
Journal:  West J Med       Date:  1982-11

2.  Pleural fluid findings as prognostic factors for malignant pleural mesothelioma.

Authors:  Tanseli Efeoglu Gonlugur; Ugur Gonlugur
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

Review 3.  A review of the management of complex para-pneumonic effusion in adults.

Authors:  Vikas Koppurapu; Nikhil Meena
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

4.  Pleural effusion in Iraq: a prospective study of 100 cases.

Authors:  F Al-Alusi
Journal:  Thorax       Date:  1986-06       Impact factor: 9.139

5.  Differential diagnosis of pleural effusions.

Authors: 
Journal:  West J Med       Date:  1982-11

6.  Quantification of pleural effusions by two-dimensional transthoracic echocardiography.

Authors:  Jeffrey Yim; Soohyun A Chang; Darwin F Yeung; Eric C Sayre; Ken Gin; John Jue; Parvathy Nair; Michael Y C Tsang; Christina Luong; Teresa S M Tsang
Journal:  J Echocardiogr       Date:  2022-08-16

7.  Cytomorphology of Boerhaave's syndrome: A critical value in cytology.

Authors:  Walid E Khalbuss; Shveta Hooda; Manon Auger
Journal:  Cytojournal       Date:  2013-04-30       Impact factor: 2.091

8.  Chylous ascites and chylothorax: a case study.

Authors:  Asmita A Mehta; Richa Gupta; T Balamugesh; D J Christopher
Journal:  Libyan J Med       Date:  2010-09-07       Impact factor: 1.657

9.  Microfluidic purification and concentration of malignant pleural effusions for improved molecular and cytomorphological diagnostics.

Authors:  James Che; Albert J Mach; Derek E Go; Ish Talati; Yong Ying; Jianyu Rao; Rajan P Kulkarni; Dino Di Carlo
Journal:  PLoS One       Date:  2013-10-28       Impact factor: 3.240

10.  Differentiating Malignant from Tubercular Pleural Effusion by Cancer Ratio Plus (Cancer Ratio: Pleural Lymphocyte Count).

Authors:  Akash Verma; Rucha S Dagaonkar; Dominic Marshall; John Abisheganaden; R W Light
Journal:  Can Respir J       Date:  2016-12-14       Impact factor: 2.409

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.